A Hsp70 mitocondrial humana (mtHsp70 ou mortalina) está envolvida em diversos processos celulares: na matriz mitocondrial atua na importação de proteínas produzidas no citoplasma; no citoplasma, pode atuar sequestrando a p53, estando assim envolvida na proliferação de alguns tipos de câncer. A literatura ainda aponta que a mortalina participa na manutenção de várias doenças causadas pelo envelhecimento, como mal de Parkinson e de Alzheimer. Desse modo, o estudo estrutural e a investigação das principais funções da mortalina in vivo e in vitro, além de sua interação com outras chaperonas e co-chaperonas é de grande relevância científica, podendo proporcionar um maior entendimento de seu papel celular e da maquinaria bioquímica nas doenças onde ela está inserida. Apesar de ser conhecida há bastante tempo, as tentativas de expressão heteróloga da mortalina recombinante resultam na sua produção na forma insolúvel, inviabilizando estudos estruturais e funcionas in vitro. Assim, as informações estruturais e funcionais desta proteína permaneceram limitadas até então. Em 2005, foi descrita uma co-chaperona da mortalina que atua auxiliando o seu enovelamento correto e em sua manutenção na fração solúvel, esta proteína mitocondrial foi denominada de hHep1 (Hsp70-escort protein 1) e por meio de sua co-expressão com a mortalina foi possível obter esta última na sua forma monomérica, solúvel e estável. Isso possibilitou realizar ensaios de caracterização estrutural e funcional da mortalina, sendo o foco principal deste trabalho de doutorado. Os resultados obtidos sugerem que a mortalina se apresenta como um monômero ligeiramente alongado em solução, sendo formada por 2 domínios com estabilidades distintas. Os ensaios funcionais revelaram uma constante de dissociação (KD) para interação com nucleotídeos adenosina da ordem de 1 µM. A mortalina apresenta atividade ATPásica com valores de Vmáx e KM da ordem de 0,21 pmol de ATP por min e 190 ± 20 µM, respectivamente. Este trabalho é pioneiro na caracterização estruturale funcional da mortalina humana e espera-se que estudos posteriores, elucidem mais detalhedamente os mecanismos de interação da mortalina com proteínas clientes nos diversos compartimentos celulares onde ela atua. / The human mitochondrial Hsp70 (mtHsp70 or mortalina) is involved in many cellular processes: in the mitochondrion matrix, mortalin acts in the process of protein importation from cytoplasm; in the cytoplasm may act by sequestering p53, protein involved in the proliferation of some kinds of cancer. The literature also shows that mortalin participates in the maintenance of various diseases caused by aging, such as Parkinson\'s and Alzheimer\'s. Thus, the structural study and research of the main functions of mortalin in vivo and in vitro, and its interaction with other chaperones and co-chaperones is of great scientific importance and may provide a greater understanding of their role and cellular biochemical machinery in diseases where it is inserted. Despite being known for a long time, the expression of heterologous mortalin resulted in an insoluble form of the protein, which precludes its in vitro structural and functional studies. Thus, structural and functional information of this protein, along with its interaction with chaperones, co-chaperones and client proteins, remained unknown. By 2005, it was described co-chaperone that acts on mortalin helping its correct folding and its maintenance in the soluble fraction, this mitochondrial protein was called hHep1 (Hsp70-escort protein 1) and through its co-expression with mortalin it was possible to obtain the recombinant mortalin in its monomeric, soluble and stable. With this protein, it was possible to perform tests of structural and functional characterization of recombinant mortalin, the main focus of this doctoral work. The results suggest that mortalin behaves as a slightly elongated monomer in solution, formed by two domains with different stabilities. Functional assays showed that the dissociation constant for interaction with adenosine nucleotide of the order of 1 µM. Mortalin has ATPase activity with Vmax and KM values of 0.21 pmol ATP per min and 190 ± 20 µM, respectively. It is expected that these results provide information for further studies, such as for elucidating the mechanisms that mortalin interacts with client proteins in various cellular compartments in which it operates.

As chaperonas moleculares são proteínas que auxiliam no enovelamento correto de outras proteínas, entre outras funções importantes para as células, motivo pelo qual elas têm sido alvo para o combate de várias doenças. As Hsp90 (82-96 kDa) são chaperonas abundantes que interagem com diversas proteínas-cliente. São constituídas por três domínios: N-terminal, intermediário ou central (M) e C-terminal, o qual é responsável pela dimerização da proteína. A atividade da Hsp90 está diretamente relacionada à sua atividade ATPásica. Durante o ciclo funcional, as Hsp90 podem interagir com inúmeras co-chaperonas. Uma delas é a co-chaperona p23 (18-22 kDa) que interage com o dímero da Hsp90 e algumas das suas funções são a inibição da atividade ATPásica e atividade chaperona. O objetivo do trabalho foi obter a proteína recombinante Hsp90 de Leishmania braziliensis e os domínios N e N+M, determinar fatores importantes que relacionam mudanças conformacionais e função da Hsp90 e as bases moleculares da inibição por GA. Também obter as co-chaperonas Lbp23A e Lbp23B e investigar a interação com a LbHsp90 e suas funções. As proteínas produzidas foram purificadas e caracterizadas por técnicas biofísicas. Em solução, a LbHsp90 foi caracterizada como dímero assimétrico e as demais proteínas como monômeros assimétricos.A interação da LbHsp90 e domínios com nucleotídeos foi analisada por fluorescência e as constantes de dissociação ficaram em torno de 150 µM. A afinidade por GA foi maior que a verificada para ATP e em ordem crescente para LbHsp90, LbHsp90_NM e LbHsp90_N. A LbHsp90 apresentou grande atividade chaperona em relação à citrato sintase, de maneira independente de ATP. A LbHsp90 mostrou baixa atividade ATPásica, a qual foi inibida pela GA com IC50 de 0,7 µM. Tanto a Lbp23A quanto a Lbp23B inibiram a atividade ATPásica da LbHsp90, porém a Lbp23A aproximou-se de 100% de inibição e a Lbp23B apenas 30%. A interação in vitro entre a LbHsp90 e a Lbp23B foi observada por pull-down na presença/ausência de nucleotídeos e essa técnica não se mostrou adequada para a Lbp23A.O pioneirismo do trabalho com a Hsp90/p23 de L. braziliensis oferece uma grande contribuição para futuros trabalhos que visam o entendimento das relações funcionais entre essas proteínas e o contexto das Hsp90 no desenvolvimento da leishmaniose. / Molecular chaperones are proteins involved in proper folding of other proteins, and others important cellular functions, why they have been targeted for combating various diseases. The Hsp90 (82-96 kDa) are ubiquitous chaperones that interact with a wide range of client proteins. They are formed by three domains: N-terminal, central or middle (M), and C-terminal, which is responsible by its dimerization. The Hsp90 activity is related to its ATPase activity. During the Hsp90 functional cycle, diverse co-chaperones. One of them is the p23 (18 kDa), that interacts with one Hsp90 dimer, and some p23 functions are the inhibition of Hsp90 ATPase activity and chaperone activity. The aim of this work was obtain the Hsp90 recombinant Leishmania braziliensis Hsp90, the N and N+M domains, to determine the important factors related to conformational changes and Hsp90 function, and the molecular basis of GA inhibition. Also, to obtain the Lbp23A and Lbp23B co-chaperones in order to establish relevant aspects for LbHsp90 interaction and its co-chaperones functions. The recombinant proteins were produced, purified and characterized by biophysics techniques. The LbHsp90 was identified as an asymmetric dimer for whereas the others were identified as asymmetric monomers. The interactions between LbHsp90 and domains with nucleotides were determined by fluorescence and the dissociation constants were about 150 µM. The GA-affinity was greater than ATP one, in increasing order for LbHsp90, LbHsp90_NM, and LbHsp90_N. The LbHsp90 showed large chaperone activity related to citrate synthase independently of ATP. The LbHsp90 presented low ATPase activity, which was inhibited by GA with a IC50 of 0,7. The Lbp23A and Lbp23B inhibited the ATPase activity with different values, the Lbp23A inhibition was closed to 100% whereas the Lbp23B one was 30%. The in vitro interaction between the LbHsp90 and Lbp23B was observed by pull-down, in the absence or presence of nucleotides, and for Lbp23A this technique was not appropriated. The pioneering work with Hsp90/p23 from L. braziliensis offers an important contribution to future studies aimed at understanding the functional relationships between these proteins and the context of Hsp90 in the development of leishmaniasis.

Lipoprotein lipase (LPL) is a central enzyme in lipid metabolism. It is a non-covalent, homodimeric and N-glycosylated protein, which is regulated in a tissue-specific manner and is dependent on an activator protein, apolipoprotein CII. Dissociation of active LPL dimers to monomers leads to loss of activity. This was previously found to be an important event in the rapid regulation of LPL in tissues. The mechanisms involved in the processing of LPL to active dimers, as well as in LPL inactivation through monomerization, were unknown. We have investigated the folding properties of the LPL protein, in particular the requirements for LPL to attain its active quaternary structure and to remain in the native conformation. On expression of LPL in insect cells we found that most of the LPL protein was synthesized in an inactive monomeric form. By co-expression of LPL with human molecular haperones, especially with calreticulin (CRT), the activity of LPL increased greatly, both in the cells and in the media. The effect of CRT on LPL activity was not due to increased levels of the LPL protein, but was due to an increased proportion of active dimeric LPL. Co-immunoprecipitation experiments showed direct interaction between LPL and CRT supporting the idea that this ER-based molecular chaperone supports the formation of active LPL dimers. We showed that, bis-ANS, the aromatic hydrophobic probe 1,1.-bis(aniline)-4,4.- bis(naphthalene)-8,8.disulfonate, can be used to obtain specific information about the interaction of LPL with lipid substrates and with apoCII. Bis-Ans was found to be a potent inhibitor of LPL activity, but apoCII prevented the inhibition. Our results suggest that bis-Ans binds to three exposed hydrophobic sites, of which one is at or close to the binding site(s) for apoCII. In studies of the mechanisms responsible for the spontaneous inactivation of LPL, we showed that active LPL is a dynamic dimer in which the subunits rapidly exchange partners. The rapid equilibrium between dimers and monomers exists even under conditions where LPL is relatively stable. This supports the idea that the dimer is in equilibrium with dimerization-competent, possibly active monomers. This dimerization-competent intermediate was also implicated in studies of the inactivation kinetics. The inactive LPL monomer was found to have a stable, defined conformation irrespective of how it was formed. The main differences in conformation between the inactive monomer and the active dimer were located in the middle part of the LPL subunit. Experiments with bis-Ans demonstrated that more hydrophobic regions were exposed in the inactive monomer, indicating a molten globule conformation. We concluded that the middle part of the LPL subunit is most likely engaged in the formation of the active LPL dimer. The dimerization-competent LPL monomer is a hypothetical conformational state, because it has not been possible to isolate it. To study complete refolding of LPL we used fully denatured LPL and were able to demonstrate that the recovery of LPL activity was about 40% when the denaturant was diluted by a buffer containing 20% human serum and 2M NaCl. Further studies identified calcium as the component in serum that was crucial for the reactivation of LPL. The refolding of LPL was shown to involve at least two steps, of which the first one was rapid and resulted in folded, but inactive monomers. The second step, from inactive monomers to active dimers, was slow and calcium-dependent. Also inactive monomers isolated from human tissue were able to recover activity under the influence of calcium. We proposed that calcium-dependent control of LPL dimerization might be involved in the normal post-translational regulation of LPL activity. In conclusion, LPL is a relatively unstable enzyme under physiological conditions due to its noncovalent dimeric structure. The energy barrier for folding to the active dimer is high and requires the presence of calcium ions and molecular chaperones to be overcome. The dimeric arrangement is probably essential to accomplish rapid down-regulation of LPL activity according to metabolic demand, e.g. in adipose tissue on fasting.

Hsp104 and ClpB are hexameric ATPases that resolubilize aggregated proteins in collaboration with the Hsp70 chaperone system. Hsp104/ClpB functionally interact only with their respective Hsp70 system and this specificity is mapped to the Hsp104/ClpB coiled-coil domain (CCD). We hypothesize that the interaction between Hsp70 and Hsp104/ClpB CCD stimulates nucleotide exchange and release of substrate from Hsp70. In the current study, the CCDs of E. coli ClpB and S. cerevisiae Hsp104 have been purified. Isolated domains are monomeric and well folded. They inhibit refolding of aggregated firefly luciferase in a species-specific manner. We found that the ATPase activity of E. coli DnaK is stimulated at low concentrations of the E. coli ClpB CCD but not by yeast Hsp104 CCD. However, in another bacterial system (Thermus thermophilus) we found that the ClpB CCD inhibits The ATPase activity of DnaK suggesting that the interaction may have different consequences in distinct chaperone networks.

Previous studies have focused on the effect of individual stressors on hsp gene expression in eukaryotic organisms. In the present study, I examined the effect of concurrent low doses of sodium arsenite and mild heat shock temperatures on the expression of hsp30 and hsp70 genes in Xenopus laevis A6 kidney epithelial cells. Northern hybridization and western blot analysis revealed that exposure of A6 cells to 1-10 μM sodium arsenite at a mild heat shock temperature of 30˚C enhanced hsp30 and hsp70 gene expression to a much greater extent than found with either stress individually. In cells treated simultaneously with 10 μM sodium arsenite and different heat shock temperatures, enhanced accumulation of HSP30 and HSP70 protein was first detected at 26˚C with larger responses at 28 and 30 ˚C. HSF1 activity was involved in combined stress-induced hsp gene expression since the HSF1 activation inhibitor, KNK437, inhibited HSP30 and HSP70 accumulation. Immunocytochemical analysis revealed that HSP30 was present in a granular pattern primarily in the cytoplasm in cells treated simultaneously with both stresses. Finally, prior exposure of A6 cells to concurrent sodium arsenite (10 μM ) and heat shock (30 ˚C) treatment conferred thermotolerance since it protected them against a subsequent thermal challenge at 37 ˚C. Acquired thermotolerance was not observed with cells treated with the two mild stresses individually. It is likely that the enhanced accumulation of HSPs under these conditions permits the organism to cope with multiple environmental stresses encountered in their natural aquatic habitat. Previous studies have shown that inhibiting the activity of the proteasome also leads to the accumulation of damaged or unfolded proteins within the cell. In the second phase of this study, I report that inhibition of proteasome activity by the inhibitors carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG132) and lactacystin induced the accumulation of HSP30 and HSP70 as well as their respective mRNAs. The accumulation of HSP30 and HSP70 in A6 cells recovering from MG132 exposure was still relatively high 24 h after treatment and it decreased substantially after 48 h. Exposing A6 cells to simultaneous MG132 and mild heat shock enhanced the accumulation of HSP30 and HSP70 to a much greater extent than with each stressor alone. HSP30 localization in A6 cells was primarily in the cytoplasm as revealed by immunocytochemistry. In some A6 cells treated with higher concentrations of MG132 and lactacystin, HSP30 was also found to localize in relatively large cytoplasmic foci. In some MG132-treated cells, HSP30 staining was substantially depleted in the cytoplasmic regions surrounding these foci. The activation of HSF1 may be involved in MG132-induced hsp gene expression in A6 cells since KNK437 inhibited the accumulation of HSP30 and HSP70. Lastly, MG132 treatment also conferred a state of thermotolerance in A6 cells such that they were able to survive a subsequent thermal challenge. Analysis of this phenomenon is important given the fact that impaired proteasomal activity has been suggested as an explanation for some of the late-onset neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease.

Previous studies have focused on the effect of individual stressors on hsp gene expression in eukaryotic organisms. In the present study, I examined the effect of concurrent low doses of sodium arsenite and mild heat shock temperatures on the expression of hsp30 and hsp70 genes in Xenopus laevis A6 kidney epithelial cells. Northern hybridization and western blot analysis revealed that exposure of A6 cells to 1-10 μM sodium arsenite at a mild heat shock temperature of 30˚C enhanced hsp30 and hsp70 gene expression to a much greater extent than found with either stress individually. In cells treated simultaneously with 10 μM sodium arsenite and different heat shock temperatures, enhanced accumulation of HSP30 and HSP70 protein was first detected at 26˚C with larger responses at 28 and 30 ˚C. HSF1 activity was involved in combined stress-induced hsp gene expression since the HSF1 activation inhibitor, KNK437, inhibited HSP30 and HSP70 accumulation. Immunocytochemical analysis revealed that HSP30 was present in a granular pattern primarily in the cytoplasm in cells treated simultaneously with both stresses. Finally, prior exposure of A6 cells to concurrent sodium arsenite (10 μM ) and heat shock (30 ˚C) treatment conferred thermotolerance since it protected them against a subsequent thermal challenge at 37 ˚C. Acquired thermotolerance was not observed with cells treated with the two mild stresses individually. It is likely that the enhanced accumulation of HSPs under these conditions permits the organism to cope with multiple environmental stresses encountered in their natural aquatic habitat. Previous studies have shown that inhibiting the activity of the proteasome also leads to the accumulation of damaged or unfolded proteins within the cell. In the second phase of this study, I report that inhibition of proteasome activity by the inhibitors carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG132) and lactacystin induced the accumulation of HSP30 and HSP70 as well as their respective mRNAs. The accumulation of HSP30 and HSP70 in A6 cells recovering from MG132 exposure was still relatively high 24 h after treatment and it decreased substantially after 48 h. Exposing A6 cells to simultaneous MG132 and mild heat shock enhanced the accumulation of HSP30 and HSP70 to a much greater extent than with each stressor alone. HSP30 localization in A6 cells was primarily in the cytoplasm as revealed by immunocytochemistry. In some A6 cells treated with higher concentrations of MG132 and lactacystin, HSP30 was also found to localize in relatively large cytoplasmic foci. In some MG132-treated cells, HSP30 staining was substantially depleted in the cytoplasmic regions surrounding these foci. The activation of HSF1 may be involved in MG132-induced hsp gene expression in A6 cells since KNK437 inhibited the accumulation of HSP30 and HSP70. Lastly, MG132 treatment also conferred a state of thermotolerance in A6 cells such that they were able to survive a subsequent thermal challenge. Analysis of this phenomenon is important given the fact that impaired proteasomal activity has been suggested as an explanation for some of the late-onset neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease.

Thesis (Ph.D. (Biochemistry, Microbiology & Biotechnology)) - Rhodes University, 2009.

Thesis (Ph. D.)--University of Washington, 2001. / Vita. Includes bibliographical references (leaves 88-102).

Thesis (Ph.D.)--Virginia Commonwealth University, 2009. / Prepared for: Dept. of Human Genetics. Title from title-page of electronic thesis. Bibliography: leaves 166-195.

Clathrin-mediated endocytosis (CME) plays a central role in the regulation of multiple cellular processes such as uptake of nutrients, recycling of housekeeping receptors and transporters, as well as for cell surface removal and downregulation of signaling receptors. Once endocytosed, cargo passes through early endosomes where sorting mechanisms traffic the cargo to the recycling pathway or to degradation in the lysosome. The general objectives of this doctoral research were to identify and characterize new players of the clathrin-mediated trafficking pathway to reveal differences between the abundant components of the trafficking machinery in two tissues, and to examine the mechanisms of endosomal sorting. / We used subcellular proteomics to reveal the differences in components of clathrin-coated vesicles (CCVs) isolated from brain and liver and to identify new molecules participating in clathrin trafficking. We demonstrated that the ratio between the clathrin adaptor proteins AP-1 and AP-2 is different in brain and liver, which indicates differential functions between the two tissues. We also discovered that clathrin-light chains, which have been proposed for many years to be regulatory proteins in the assembly of CCVs, were less abundant relative to clathrin-heavy chain in liver and in non-brain tissues compared to brain. / We identified a new DnaJ domain-containing protein, receptor-mediated endocytosis protein 8 (RME-8) that was detected in liver CCVs specifically. Further characterization revealed that the RME-8 DnaJ domain binds to the chaperone heat-shock cognate 70 (Hsc70) in an ATP-dependent manner. RME-8 is a ubiquitously expressed protein that tightly associates with endosomes, and its depletion causes intracellular trafficking defects. Moreover, we demonstrated that RME-8 depletion also leads to a decrease in levels of epidermal growth factor receptor (EGFR), as a result of an increase in EGFR degradation. RME-8 knock-down causes decreased EGFR levels even in cancer cells lines where EGFR is generally protected from degradation. / Globally this doctoral project revealed new insights on specialized functions for c1athrin-mediated trafficking in different tissues and allowed the identification and characterization of a novel protein implicated in sorting decisions occurring on endosomes.